Non-invasive tests for Morquio A
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism, Skin clinical trials.
This trial studies Morquio A (MPS IVA) using non-invasive ways to measure how the body is working, and to better understand why the condition happens. If you have Morquio A, this may help researchers learn more and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have Morquio A (also called MPS IVA).
- Your Morquio A diagnosis must be confirmed by a blood or white blood cell enzyme test showing less than 5% of normal enzyme activity.
- You likely need to provide proof/results of that enzyme test for screening.
- There are no listed exclusion criteria, so other health issues (beyond Morquio A confirmation) are not stated here.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with MPS, a rare genetic condition, to learn more about the disease over time. If you have a confirmed MPS diagnosis, you may be able to join.
This early-stage trial tests JR-446, a new treatment for MPS IIIB, a rare genetic disorder that affects the brain and body. The treatment is delivered directly into the fluid around the spinal cord and aims to slow or improve symptoms in young children.
This study tests a new gene therapy called JWK008 for adults with MPS type I. The goal is to see if it is safe and can help improve symptoms. You may be able to join if you are 18 or older and have not had serious side effects from enzyme replacement therapy.
This study looks at the nutrition and growth of children with mucopolysaccharidosis (MPS), a group of rare genetic conditions. The goal is to understand their nutritional needs to improve care and quality of life.
This trial looks for new markers of Charcot-Marie-Tooth 1A (CMT1A) early in the disease. Researchers hope to find signs that can help diagnose and track the disease better, which could lead to better treatments in the future.
This study follows people with MPS IIIC over time to learn more about how the disease progresses. It does not test a new treatment, but the information may help with future care and research.
Hear when a new MPS IVA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.